BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/12/2025 7:01:28 AM | Browse: 23 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 108662
Country China
Category Immunology
Manuscript Type Basic Study
Article Title Histone deacetylases 10 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Hai-Hang Nie, Xue-Ying Yang, Jing-Kai Zhou, Gui-Lin Gao, Lu Ding, Yun-Tian Hong, Ya-Li Yu, Pei-Shan Qiu, Zi-Yue Zeng, Jun Lai, Ting Zheng, Hai-Zhou Wang, Qiu Zhao and Fan Wang
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 82403279 and 82303181
Corresponding Author Fan Wang, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuhan 430070, Hubei Province, China. 2020283030092@whu.edu.cn
Key Words Histone deacetylases 10; Colorectal cancer; Tumor microenvironment; Immunotherapy; Prognosis
Core Tip Histone deacetylases 10 (HDAC10), a HDAC family member, was overexpressed in colorectal cancer (CRC) and associated with poor prognosis. HDAC10 depletion inhibited CRC cell proliferation and migration, suggesting its oncogenic role. Gene set variation analysis linked elevated HDAC10 expression to immunosuppressive pathways and a non-inflamed tumor microenvironment (TME), characterized by reduced immune cell infiltration. CRC patients with high HDAC10 levels showed reduced sensitivity to immunotherapy, indicating therapeutic resistance. Our findings highlight HDAC10’s critical role in shaping the TME, treatment response, and clinical outcomes in CRC, supporting its potential as a therapeutic target to improve CRC management.
Citation Nie HH, Yang XY, Zhou JK, Gao GL, Ding L, Hong YT, Yu YL, Qiu PS, Zeng ZY, Lai J, Zheng T, Wang HZ, Zhao Q, Wang F. Histone deacetylases 10 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer. World J Gastroenterol 2025; In press
Received
2025-04-21 03:42
Peer-Review Started
2025-04-21 03:42
To Make the First Decision
Return for Revision
2025-05-10 18:01
Revised
2025-05-18 02:45
Second Decision
2025-06-12 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-06-12 07:01
Articles in Press
2025-06-12 07:01
Publication Fee Transferred
2025-05-20 01:21
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com